Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

Isabelle Boutron1, Lydia Guittet, Candice Estellat

  • 1INSERM, U738, Paris, France. isabelle.boutron@bch.ap-hop-paris.fr

Plos Medicine
|February 22, 2007
PubMed
Abstract

Insights

Blinding in nonpharmacological treatment trials is challenging but achievable. This study details creative blinding methods for participants, caregivers, and assessors in randomized controlled trials.

Area of Science:

  • Clinical Trials Methodology
  • Evidence-Based Practice
  • Health Research Evaluation

Background:

  • Blinding is crucial for unbiased treatment evaluation in clinical trials.
  • Achieving effective blinding is particularly challenging for nonpharmacological interventions.
  • Creative and nonstandard methods are often employed to ensure blinding.

Purpose of the Study:

  • To systematically describe the diverse strategies used for blinding in randomized controlled trials (RCTs) of nonpharmacological treatments.
  • To provide a classification of blinding methods applicable to nonpharmacological interventions.
  • To inform researchers and readers on assessing the quality of blinding in such studies.

Main Methods:

  • Systematic search of Medline and Cochrane Methodology Register for RCTs published in 2004.
  • Data extraction using a standardized form to identify and categorize blinding techniques.
  • Analysis of 145 identified articles, focusing on the 123 that described blinding methods.

Main Results:

  • Sham procedures (e.g., simulated surgery, attention controls, placebo administration) were common for participants and providers.
  • Device trials utilized placebo interventions like sham prostheses or inactivated/shielded apparatus.
  • Blinding outcome assessors involved centralized review of examinations (paraclinical, clinical via video/audio) and event adjudication.

Conclusions:

  • This study offers a classification of blinding methods for nonpharmacological trials.
  • Detailed descriptions of these methods can help overcome blinding barriers.
  • The findings aid in evaluating the quality and reliability of results from nonpharmacological intervention studies.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596